Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Profit After Tax (2016 - 2025)

iBio (IBIO) has disclosed Profit After Tax for 16 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 106.07% to -$9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.7 million, a 151.42% decrease, with the full-year FY2025 number at -$18.4 million, down 19.0% from a year prior.
  • Profit After Tax was -$9.0 million for Q4 2025 at iBio, down from -$5.7 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.1 million in Q2 2024 to a low of -$33.6 million in Q4 2022.
  • A 5-year average of -$7.4 million and a median of -$5.7 million in 2023 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: tumbled 925.83% in 2022, then surged 123.38% in 2024.
  • iBio's Profit After Tax stood at -$7.2 million in 2021, then crashed by 366.6% to -$33.6 million in 2022, then soared by 75.53% to -$8.2 million in 2023, then skyrocketed by 46.85% to -$4.4 million in 2024, then tumbled by 106.07% to -$9.0 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Profit After Tax are -$9.0 million (Q4 2025), -$5.7 million (Q3 2025), and -$5.2 million (Q2 2025).